A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Public ClinicalTrials.gov record NCT03512353. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Phase 2 Study of Carfilzomib Plus Dexamethasone To Assess Tolerability and Adherence in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective was to describe the safety profile of carfilzomib plus dexamethasone regimen in adults with relapsed or refractory multiple myeloma (RRMM) with 1 to 3 prior lines of therapy at study entry.
Study identification
- NCT ID
- NCT03512353
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 7 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 5, 2018 (Actual)
- Primary completion
- Jan 16, 2020 (Actual)
- Completion
- Jan 16, 2020 (Actual)
- Last update posted
- Jan 8, 2021
2018 – 2020
United States locations
- U.S. sites
- 31
- U.S. states
- 19
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Palm Springs | California | 92262 | — |
| Research Site | Riverside | California | 92501 | — |
| Research Site | Glenwood Springs | Colorado | 81601 | — |
| Research Site | Boynton Beach | Florida | 33426 | — |
| Research Site | Orange City | Florida | 32763 | — |
| Research Site | Pensacola | Florida | 32504 | — |
| Research Site | Honolulu | Hawaii | 96813 | — |
| Research Site | River Forest | Illinois | 60305 | — |
| Research Site | Tinley Park | Illinois | 60487 | — |
| Research Site | Indianapolis | Indiana | 46260 | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Bethesda | Maryland | 20817 | — |
| Research Site | Midland | Michigan | 48640 | — |
| Research Site | Jackson | Mississippi | 39202 | — |
| Research Site | Lincoln | Nebraska | 68506 | — |
| Research Site | Florham Park | New Jersey | 07932 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | Hendersonville | North Carolina | 28792 | — |
| Research Site | Pinehurst | North Carolina | 28374 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Zanesville | Ohio | 43701 | — |
| Research Site | Charleston | South Carolina | 29414 | — |
| Research Site | Rock Hill | South Carolina | 29732 | — |
| Research Site | Corpus Christi | Texas | 78412 | — |
| Research Site | Fort Worth | Texas | 76104 | — |
| Research Site | Houston | Texas | 77057 | — |
| Research Site | Houston | Texas | 77090 | — |
| Research Site | Ogden | Utah | 84405 | — |
| Research Site | Fredericksburg | Virginia | 22408 | — |
| Research Site | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03512353, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2021 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03512353 live on ClinicalTrials.gov.